<DOC>
	<DOC>NCT00033072</DOC>
	<brief_summary>The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.</brief_summary>
	<brief_title>Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1</brief_title>
	<detailed_description>To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg &amp; 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Volunteers who meet DSM4 criteria for methamphetamine abuse or dependence; nontreatment seeking individuals Be able to verbalize understanding of consent form; provide written informed consent Please contact site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2003</verification_date>
</DOC>